124 related articles for article (PubMed ID: 6589964)
21. Effect of hypoxia on the contractile response to KCl, prostaglandin F2 alpha, and hemoglobin.
Nakagomi T; Kassell NF; Sasaki T; Fujiwara S; Lehman RM; Johshita H; Torner JC
J Neurosurg; 1987 Oct; 67(4):565-72. PubMed ID: 3477614
[TBL] [Abstract][Full Text] [Related]
22. Pharmacology of bucindolol in isolated canine vascular smooth muscle.
Rimele TJ; Aarhus LL; Lorenz RR; Rooke TW; Vanhoutte PM
J Pharmacol Exp Ther; 1984 Nov; 231(2):317-25. PubMed ID: 6149305
[TBL] [Abstract][Full Text] [Related]
23. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
Kikkawa K; Murata S; Nagao T
Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
[TBL] [Abstract][Full Text] [Related]
24. Analysis of the effects of adenosine in skinned bovine coronary artery.
Ramagopal MV; Mustafa SJ
J Pharm Pharmacol; 1992 Feb; 44(2):133-5. PubMed ID: 1352816
[TBL] [Abstract][Full Text] [Related]
25. Vasomotor changes in isolated coronary arteries from diabetic rats.
Sjögren A; Edvinsson L
Acta Physiol Scand; 1988 Nov; 134(3):429-36. PubMed ID: 3227958
[TBL] [Abstract][Full Text] [Related]
26. Aortic coarctation: the in vitro response to noradrenaline, potassium and prostaglandin F2 alpha in intercostal arteries.
Sehested J; Mikkelsen E
Gen Pharmacol; 1983; 14(1):155-6. PubMed ID: 6572166
[No Abstract] [Full Text] [Related]
27. Verapamil, diltiazem and nifedipine block the depolarization-induced potentiation of norepinephrine contractions in rabbit aorta and porcine coronary arteries.
Hondeghem LM; Ayad MJ; Robertson RM
J Pharmacol Exp Ther; 1986 Dec; 239(3):808-13. PubMed ID: 3795042
[TBL] [Abstract][Full Text] [Related]
28. The selective inhibition of serotonin-induced contractions of rabbit cerebral vascular smooth muscle by calcium-antagonistic dihydropyridines. An investigation of the mechanism of action of nimodipine.
Towart R
Circ Res; 1981 May; 48(5):650-7. PubMed ID: 7214673
[TBL] [Abstract][Full Text] [Related]
29. Influence of trimetazidine, an antianginal drug, on isolated dog arteries and veins.
Toda N; Usui H; Osumi S; Kanda M; Kitao K
Arch Int Pharmacodyn Ther; 1982 Dec; 260(2):230-43. PubMed ID: 6819825
[TBL] [Abstract][Full Text] [Related]
30. Effect of adenosine and its analogues on calcium influx in coronary artery.
Ramagopal MV; Mustafa SJ
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1492-8. PubMed ID: 3202209
[TBL] [Abstract][Full Text] [Related]
31. Responsiveness of isolated monkey coronary arteries contracted with alpha 1- and alpha 2-adrenoceptor agonists to diltiazem.
Toda N
Eur J Pharmacol; 1988 Mar; 147(2):291-3. PubMed ID: 2896597
[TBL] [Abstract][Full Text] [Related]
32. Crystalloid cardioplegia and hypothermia do not impair endothelium-dependent relaxation or damage vascular smooth muscle of epicardial coronary arteries.
Evora PR; Pearson PJ; Schaff HV
J Thorac Cardiovasc Surg; 1992 Nov; 104(5):1365-74. PubMed ID: 1434718
[TBL] [Abstract][Full Text] [Related]
33. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
[TBL] [Abstract][Full Text] [Related]
34. The effect of diltiazem, a calcium channel blocking agent, on vasoconstrictor responses to norepinephrine, serotonin and potassium depolarization in canine coronary and femoral arteries.
Mullett M; Gharaibeh M; Warltier DC; Gross GJ
Gen Pharmacol; 1983; 14(2):259-64. PubMed ID: 6840509
[TBL] [Abstract][Full Text] [Related]
35. Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.
Gan BS; Hollenberg MD; MacCannell KL; Lederis K; Winkler ME; Derynck R
J Pharmacol Exp Ther; 1987 Jul; 242(1):331-7. PubMed ID: 3497258
[TBL] [Abstract][Full Text] [Related]
36. Alpha-adrenoceptor subtypes and diltiazem actions in isolated human coronary arteries.
Toda N
Am J Physiol; 1986 May; 250(5 Pt 2):H718-24. PubMed ID: 2871765
[TBL] [Abstract][Full Text] [Related]
37. Potassium-induced release of endothelium-derived relaxing factor from canine femoral arteries.
Rubanyi GM; Vanhoutte PM
Circ Res; 1988 Jun; 62(6):1098-103. PubMed ID: 3260148
[TBL] [Abstract][Full Text] [Related]
38. Ouabain inhibits endothelium-dependent relaxations to arachidonic acid in canine coronary arteries.
Rubanyi GM; Vanhoutte PM
J Pharmacol Exp Ther; 1985 Oct; 235(1):81-6. PubMed ID: 3930700
[TBL] [Abstract][Full Text] [Related]
39. Effects of prostaglandin F2 alpha on vasoconstrictor responses in the mesenteric vascular bed.
Aristegui PM; Enero MA
Hypertension; 1988 Feb; 11(2 Pt 2):I108-11. PubMed ID: 3162232
[TBL] [Abstract][Full Text] [Related]
40. A possible mechanism involved in generation of automaticity of isolated human renal artery.
Ueda S; Ikegami K; Yonemura K; Sakanashi M
Arch Int Pharmacodyn Ther; 1982 Apr; 256(2):204-11. PubMed ID: 6954880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
